C4 Therapeutics Q1 2026 Earnings Strong EPS Beat Highlights Cost Discipline Amid PreRevenue Stage Sensei Biotherapeutics SNSE Q1 2026 Earnings Massive EPS Miss Overshadowed by Upbeat Sentiment ArrowMark Financial Corp BANX Q4 2022 Earnings Slight EPS Miss Amid Stable Performance UPLD Q1 2026 Earnings EPS Surges Past Expectations Stock Reacts Positively Weyco Group Q1 2026 Earnings Steady EPS Performance Amid Challenging Retail Environment FDBC Q4 2025 Earnings Steady EPS Performance Amid Quiet Market Response